US EditionPublished • loading... • Updated
China Approves World's First Brain Implant for Commercial Use
The coin-sized wireless implant enables hand grasping in paralysis patients and has shown significant improvements in clinical trials, marking a first in commercial invasive brain-computer interfaces.
- On Friday, China's National Medical Products Administration cleared registration of Neuracle Medical Technology's implantable BCI-based hand motor function system, enabling its commercial launch in China.
- China has elevated BCI to a national strategic priority, including it in this year's government work report and the 15th Five-Year Plan, while increased investment fuels domestic BCI industry growth.
- Neuracle's system uses a coin-sized wireless epidural implant that records signals above the dura and controls a pneumatic glove for eligible patients aged 18 to 60 with cervical spinal cord injuries, showing clinical improvements.
- Shares of BCI companies rose on Friday, with Shenzhen-listed Inkon Life Technology surging more than 10 per cent, as industry observers called the approval a milestone that could accelerate commercialization.
- No BCI has U.S. commercial approval, and surgical safety experts warn implants carry risks like infection and scar-tissue degradation; global firms including Neuralink, Synchron, Paradromics, and Shanghai NeuroXess intensify the race.
Insights by Ground AI
16 Articles
16 Articles
China approves world's first invasive BCI medical device
China has approved the world's first invasive Brain–Computer Interface (BCI) medical device for market use, marking the start of clinical application for the emerging technology.The National Medical Products Administration (NMPA) recently cleared the
·Beijing, China
Read Full Article
Coverage Details
Total News Sources16
Leaning Left5Leaning Right1Center4Last UpdatedBias Distribution50% Left
Bias Distribution
- 50% of the sources lean Left
50% Left
L 50%
C 40%
Factuality
To view factuality data please Upgrade to Premium
